Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Market Intel: When Reality Techs Kick In - How VR, AR And MR Are Revolutionizing Surgery

Executive Summary

Whether used for training surgeons outside of the operating room or as a valuable reference tool during surgery, the recent AAOS annual conference shows that orthopedic surgeons rank among several pioneering clinician groups who are embracing surgical solutions that extend into the worlds of virtual, augmented, and mixed reality. With the global shift toward value-based health care, Proponents say these new technologies may offer surgeons new ways to improve operating times and efficiency, better patient outcomes and cut overall costs.

You may also be interested in...



Market Intel: Medtechs, Surgeons Embrace ‘Virtual Operating Theater’ As New Reality

In this first part of a three-part series on the “Future of Surgery” we introduce three companies that developed telehealth platforms allowing for virtual collaborations during live surgeries. The second part will discuss AI, VR and AR in the OR.

Brainlab Receives FDA Clearance For Imaging Robot, Alignment Module For Spine

Brainlab is expanding its digital surgery portfolio with the FDA clearance for imaging and alignment module systems.

Theator Raises $15.5M To Bring AI-Based Surgical Platform To US Academic Medical Centers

Theator plans to expand its AI-powered surgical technology platform beyond general surgery and gain a foothold in the US.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel